Institutional equity research analysts covering Agilent Technologies, Inc. (NYSE: A) maintain a consensus 12-month average price target reflecting steady growth in life sciences, diagnostics, and applied chemical markets. Target forecasts generally position the stock with moderate upside based on resilient laboratory instrument demand and recurring software revenues.